Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis. Unidade: FM
Assunto: CARDIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIGHETTI, E. J. B et al. Cyprofibrate treatment increases CETP and decreases hepatic lipase activities in normolipidemic but not in hypertriglyceridemic CETP transgenic mice. Atherosclerosis. Holanda: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 16 set. 2024. , 2000APA
Bighetti, E. J. B., Nunes, V. S., Quintão, E. C. da R., Casquero, A. C., Faria, E. C. de, Carneiro, E. M., et al. (2000). Cyprofibrate treatment increases CETP and decreases hepatic lipase activities in normolipidemic but not in hypertriglyceridemic CETP transgenic mice. Atherosclerosis. Holanda: Faculdade de Medicina, Universidade de São Paulo.NLM
Bighetti EJB, Nunes VS, Quintão EC da R, Casquero AC, Faria EC de, Carneiro EM, Berti JA, Oliveira HCF. Cyprofibrate treatment increases CETP and decreases hepatic lipase activities in normolipidemic but not in hypertriglyceridemic CETP transgenic mice. Atherosclerosis. 2000 ; 151( 01): 221.[citado 2024 set. 16 ]Vancouver
Bighetti EJB, Nunes VS, Quintão EC da R, Casquero AC, Faria EC de, Carneiro EM, Berti JA, Oliveira HCF. Cyprofibrate treatment increases CETP and decreases hepatic lipase activities in normolipidemic but not in hypertriglyceridemic CETP transgenic mice. Atherosclerosis. 2000 ; 151( 01): 221.[citado 2024 set. 16 ]